ICMJE (International Committee of Medical Journal Editors)

The International Committee of Medical Journal Editors (ICMJE) is a small, self-funded working group of editors from a defined set of general medical journals and related organizations. It meets annually and produces the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals — a document that has become the de facto reference standard for authorship, disclosure, and editorial practice across biomedical publishing, even though ICMJE has no legal, licensing, or enforcement authority over any journal.

Origin and current membership

ICMJE traces to an informal 1978 meeting of medical journal editors in Vancouver, British Columbia — the group became known as the “Vancouver Group.” Its manuscript-format requirements were first published in 1979 as the Uniform Requirements for Manuscripts Submitted to Biomedical Journals; the document was renamed to its current title in 2013 as its scope broadened from manuscript formatting to editorial ethics more generally (corroborated across PMC, NEJM, and Wikipedia’s ICMJE recommendations entry — not independently re-confirmed against an ICMJE-hosted history page this session).

ICMJE’s own About page describes it as “a small working group of general medical journal editors whose participants meet annually and fund their own work” on the Recommendations. Membership is currently 17 organizations, including individual journals (Annals of Internal Medicine, The BMJ, JAMA, The Lancet, NEJM, Nature Medicine, PLOS Medicine, and others), the U.S. National Library of Medicine, and the World Association of Medical Editors (WAME). Membership is by invitation to specific journal editors and organizations — there is no application or dues-paying membership process open to journals generally, which is a structural difference from a body like COPE (Committee on Publication Ethics), whose membership model is open and fee-based.

Operational definition

A concept, requirement, or document is properly described as “ICMJE” when it originates from, or is directly required by, the ICMJE Recommendations themselves — not merely when it reflects general “good journal ethics” language. Concretely, this covers:

• Authorship criteria — the four-part test (substantial contribution; drafting or critically revising the work; final approval of the version to be published; agreement to be accountable for all aspects of the work) that determines who qualifies as an author, distinct from CRediT’s contribution-description taxonomy.
• Conflict-of-interest / disclosure requirements — the ICMJE Disclosure Form (renamed from a “conflicts of interest” form to a “disclosure form” in 2021), submitted to the journal, never to ICMJE itself.
• Clinical trial registration policy — prospective registration (before enrollment begins) in a WHO-recognized public trial registry, first announced in 2004 and effective for trials enrolling on or after 1 July 2005, later extended to require a data-sharing statement (2018) and, for trials beginning enrollment from 1 January 2019, a data-sharing plan as part of registration.
• Editorial and publishing issues — corrections and retractions, overlapping/duplicate publication (including how preprints are treated), peer-review conduct, and, as of a recent update, use of generative AI by authors, reviewers, and editors.

Content that merely gestures at “publication ethics” without tying back to one of these specific, named ICMJE positions is not, in the operational sense, “ICMJE” content — it may instead reflect COPE guidance, a publisher’s own house policy, or general norms with no single named source.

Worked examples

Example 1 — authorship and disclosure at submission. A journal’s “Instructions for Authors” page states that manuscripts must satisfy the ICMJE’s four authorship criteria and that every listed author must complete the ICMJE Disclosure Form before peer review begins. This is a direct, named application of ICMJE Recommendations — see CASRAI’s guide on conflict of interest disclosure in scholarly publication and on corresponding author responsibilities.

Example 2 — prospective trial registration. A clinical trial is registered in ClinicalTrials.gov (a WHO ICTRP primary registry) before the first participant is enrolled, specifically because the target journal’s submission policy requires it as a condition of considering the manuscript — this is the ICMJE clinical-trial-registration policy in operation, distinct from and broader in scope than FDAAA 801/NIH results-reporting requirements. See CASRAI’s guide on clinical trial registration and reporting compliance.

Counter-example

A journal’s website stating it is “committed to the highest standards of research integrity and publication ethics,” with no reference to ICMJE’s authorship criteria, disclosure form, or registration policy, is not an instance of ICMJE adoption — it’s a generic ethics statement. Likewise, a journal cannot “join” ICMJE the way it can become a dues-paying COPE member; only the editors of ICMJE’s 17 member organizations sit on the committee itself. Every other journal that “follows” the Recommendations does so by voluntary self-attestation, with no formal enrollment, certification, or audit by ICMJE confirming actual compliance.

Influence without regulatory authority

ICMJE is frequently — and inaccurately — described as a regulator or accrediting body for medical publishing. It is neither. It has no statutory power, cannot compel a journal to adopt its Recommendations, and does not certify or audit journals that claim to follow them. Its influence is entirely reputational and network-driven: because a critical mass of high-impact general medical journals (and organizations such as WAME and the U.S. National Library of Medicine) participate directly, and because thousands of other biomedical journals worldwide have voluntarily adopted the Recommendations as their own editorial policy, ICMJE’s positions function as a widely shared reference standard even though no formal mechanism enforces them. This is the same pattern seen with COPE‘s Core Practices and flowcharts — de facto authority built on voluntary, reputational adoption rather than legal mandate.

Related terms

• COPE (Committee on Publication Ethics)
• Retraction
• Co-corresponding author convention
• Data availability statement
• Guide: Corresponding author responsibilities
• Guide: Conflict of interest disclosure in scholarly publication
• Guide: Clinical trial registration and reporting compliance
• Guide: Can AI be listed as an author? ICMJE, COPE, and publisher positions